Evidence map›Paper›PMID 20135240›Full record

ReviewImmunologic research2010

Mechanisms involved in antibody- and complement-mediated allograft rejection.

Barbara A Wasowska

Abstract readReview
In one paragraph

Review in Immunologic research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Article
  3. Ablation of FAS confers allogeneic CD3Nature biomedical engineering · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The Role of Neutrophils in Transplanted Organs.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2017
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Novel functions of B cells in transplantation.Current opinion in organ transplantation · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Barbara A WasowskaDepartment of Pathology, The Johns Hopkins University School of Medicine, Ross Bldg. 664B, Baltimore, MD 21205, USA. bwasowsk@jhmi.edu
Johns Hopkins Medicine · US

Funding

MECHANISMS OF ANTIBODY MEDIATED ALLOGRAFT REJECTIONR01HL063948 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI WASOWSKA, BARBARA A · 2000 to 2003
$1.3M
NHLBI NIH HHS R01 HL063948NHLBI NIH HHS R01-HL63948
6 · The paper itself

Abstract

Antibody-mediated rejection has become critical clinically because this form of rejection is usually unresponsive to conventional anti-rejection therapy, and therefore, it has been recognized as a major cause of allograft loss. Our group developed experimental animal models of vascularized organ transplantation to study pathogenesis of antibody- and complement-mediated endothelial cell injury leading to graft rejection. In this review, we discuss mechanisms of antibody-mediated graft rejection resulting from activation of complement by C1q- and MBL (mannose-binding lectin)-dependent pathways and interactions with a variety of effector cells, including macrophages and monocytes through Fcgamma receptors and complement receptors.

Indexed as

AnimalsComplement ActivationDisease Models, AnimalEndothelial CellsGraft RejectionHeart TransplantationHumansIsoantibodiesMacrophagesMiceMice, Inbred C57BLMonocytesIsoantibodies

Identifiers

PMID20135240
PMCPMC2892186
OpenAlexW2042872673

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.